1786 — Scivision Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Scivision Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	413	696	674	804	871
Net Total Accounts Receivable
Net Total Receivables	68.2	78.9	91.5	96.2	174
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	553	925	881	1,004	1,166
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,296	1,246	1,184	1,135	1,176
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,891	2,262	2,098	2,160	2,354
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	122	426	128	145	337
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	487	812	587	534	457
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,404	1,450	1,511	1,627	1,897
Total Liabilities & Shareholders' Equity	1,891	2,262	2,098	2,160	2,354
Total Common Shares Outstanding